Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05256576
What this trial is testing

KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer

Who this might be right for
Ovary CancerFallopian Tube CancerPeritoneum Cancer+1 more
Charite University, Berlin, Germany 465
Large-scale testing (Phase 3)Study completedNCT00002717
What this trial is testing

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 324
Testing effectiveness (Phase 2)Ended earlyNCT00505661
What this trial is testing

Letrozole in Patients With Ovarian Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
M.D. Anderson Cancer Center 16
Not applicableLooking for participantsNCT05129969
What this trial is testing

Registry Platform Ovarian and Endometrial Cancer

Who this might be right for
Ovarian CancerEndometrial CancerOvary Neoplasm+4 more
iOMEDICO AG 1,975
Large-scale testing (Phase 3)Active Not RecruitingNCT02502266
What this trial is testing

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Serous Adenocarcinoma+12 more
National Cancer Institute (NCI) 582
Early research (Phase 1)Study completedNCT00562003
What this trial is testing

Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
University of Alabama at Birmingham 26
Testing effectiveness (Phase 2)Study completedNCT00510653
What this trial is testing

Gleevec Study for Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 73
Early research (Phase 1)Not Yet RecruitingNCT06846424
What this trial is testing

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CarcinomaPeritoneal Carcinoma
Shanghai Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)UnknownNCT01739894
What this trial is testing

Feasibility Study of Intraperitoneal Paclitaxel

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 20
Testing effectiveness (Phase 2)WithdrawnNCT05672095
What this trial is testing

Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+3 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00003967
What this trial is testing

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)WithdrawnNCT01131039
What this trial is testing

Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube NeoplasmsOvarian CancerPrimary Peritoneal
Emory University
Testing effectiveness (Phase 2)Study completedNCT00377429
What this trial is testing

Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy

Who this might be right for
Ovarian Cancer
Neovii Biotech 47
Early research (Phase 1)Study completedNCT03023319
What this trial is testing

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungMesotheliomaBladder Cancer+5 more
Nagla Abdel Karim 6
Testing effectiveness (Phase 2)Study completedNCT02948075
What this trial is testing

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Ovarian Cancer
NewVac LLC 31
Testing effectiveness (Phase 2)WithdrawnNCT04510584
What this trial is testing

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Who this might be right for
Ovarian Endometrioid TumorFallopian Tube CancerPrimary Peritoneal Cancer+1 more
University Health Network, Toronto
Not applicableLooking for participantsNCT07702799
What this trial is testing

Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer

Who this might be right for
Endometrial Cancer
Mahmut Yassa 100
Not applicableStudy completedNCT01242436
What this trial is testing

Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis

Who this might be right for
Ovarian CancerPeritoneal Metastasis
Universitaire Ziekenhuizen KU Leuven 50
Testing effectiveness (Phase 2)Study completedNCT01610206
What this trial is testing

Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Linda R Duska 148
Next Page